An interventional study of Ultrasound-guided cryoneurolysis and Bipolar radiofrequency ablation in Cryoneurolysis, Bipolar Radiofrequency Ablation and Genicular Nerves, sponsored by National Cancer Institute, Egypt. Recruiting at 1 site in Egypt. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by National Cancer Institute, Egypt · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 76th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 25 of the 33 other live ones, and was the 88th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 18+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 18+
German International University · Sites in Egypt
Ages 40+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2011; this study’s year is marked. 15 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 62 across the 83 interventional studies, 69 across the 8 observational. Of the 50 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 91 has an industry lead sponsor. The 10 most frequent:
National Cancer Institute, Egypt is the lead sponsor of 134 studies on the registry; 30 are open to participants now.
National Cancer Institute, Egypt has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
11 of the studies in Osteoarthritis, Knee with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07664371Tanta UniversityCryoneurolysis Versus Radiofrequency in Knee Osteoarthritis | 2026-11 |
| NCT07468734German International UniversityShock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis | 2026-11-30 |
| NCT07666347Tanta UniversityIntraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis | 2026-12-01 |
| NCT07478861Beni-Suef UniversityWhole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis | 2027-02-15 |
Add all 11 to your calendar (.ics) → With an account.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the reduction in knee pain between ultrasound-guided cryoneurolysis and bipolar radiofrequency ablation (RFA), as measured by the Numerical Rating Scale (NRS) at predefined follow-up intervals.
Knee osteoarthritis (KOA) is a major cause of chronic pain and disability worldwide. Pain in knee osteoarthritis is multifactorial and does not always correlate with the degree of radiographic degeneration. In addition to structural joint changes, pain results from synovial inflammation, subchondral bone remodeling, periosteal irritation, ligamentous stress, and sensitization of peripheral and central nociceptive pathways.
Among the available interventional approaches, radiofrequency ablation (RFA) and cryoneurolysis have gained increasing attention because they interrupt pain transmission without affecting joint stability. Radiofrequency ablation (RFA) and cryoneurolysis are two emerging techniques that modulate pain transmission pathways. Bipolar radiofrequency ablation uses thermal energy delivered between two closely positioned electrodes to create a larger and more continuous lesion than conventional monopolar RFA.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will undergo ultrasound-guided cryoneurolysis
Procedure: Ultrasound-guided cryoneurolysis
Patients will undergo bipolar radiofrequency ablation
Procedure: Bipolar radiofrequency ablation
Patients will undergo ultrasound-guided cryoneurolysis
Patients will undergo bipolar radiofrequency ablation
Degree of pain
Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable").
Time frame: 6 months after procedure
Knee Injury and Osteoarthritis Outcome Score
Knee Injury and Osteoarthritis Outcome Score (KOOS) will measure * Pain * Symptoms * Activities of daily living * Sports/recreation * Quality of life
Time frame: 6 months after procedure
Western Ontario and McMaster Universities Osteoarthritis Index
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index is a widely used, self-administered questionnaire that evaluates pain, stiffness, and physical function in patients with knee and hip osteoarthritis.
Time frame: 6 months after procedure
Oxford Knee Score
The Oxford Knee Score is a 12-item patient-reported questionnaire used to assess pain and physical function in the knee. Score Interpretation 0 to 19 (Severe): May indicate severe knee problems or advanced arthritis; surgical intervention like a knee replacement may be considered. 20 to 29 (Moderate to Severe): Reflects considerable pain and functional limitations. 30 to 39 (Mild to Moderate): Suggests mild-to-moderate joint issues with some activity limitations. 40 to 48 (Satisfactory): Indicates normal or satisfactory joint function with minimal knee problems.
Time frame: 6 months after procedure
Patient Global Impression of Change (PGIC)
The traditional Patient Global Impression of Change (PGIC) uses a 7-point scale where patients select the statement that best describes their current state compared to how they felt before treatment: 1. Very much improved (or Much better) 2. Much improved 3. Minimally improved 4. No change (or The same) 5. Minimally worse 6. Much worse 7. Very much worse (or Very much worse)
Time frame: 6 months after procedure
Measurement of quality of life
Quality of life will be assessed using EuroQol 5-Dimension 5-Level (EQ-5D-5L).
Time frame: 6 months after procedure
Total analgesic consumption
Total analgesic consumption will be recorded.
Time frame: 24 hours after procedure
Incidence of complication
Incidence of complication will be recorded.
Time frame: 24 hours after procedure
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 6 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Institute, Egypt →